Efficacy and Safety of Tolterodine in a Predominantly Continent Population of Male Patients With Overactive Bladder and Nocturia

Abrams P1, Kaplan S2, Guan Z3, Wang J T3, Roehrborn C G4 1. Bristol Urological Insitute, 2. Columbia University, 3. Pfizer, Inc, 4. The University of Texas Southwestern Medical Center at Dallas

Abstract Category

LUTS in Men

Abstract 57
Overactive Bladder:Chaired by Sherif Mourad and Thomas Mainprize
Scientific Podium Poster Session 8
Thursday 1st September 2005
12:15 - 12:22
Links

Abstract

19/04/2024 16:32:52